Combining hard and soft magnetism into a single core-shell nanoparticle to achieve both hyperthermia and image contrast

References

• 1 Tsiapa I, Efthimiadou EK, Fragogeorgi E et al. Tc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of alphabeta-mediated tumor expression and feasibility for hyperthermia treatment. J. Colloid Interface Sci. 433C, 163–175 (2014).
  Google Scholar
• 2 Yuan C, An Y, Zhang J et al. Magnetic nanoparticles for targeted therapeutic gene delivery and magnetic-inducing heating on hepatoma. Nanotechnology 25(34), 345101 (2014).
  MedlineGoogle Scholar
• 3 Majeed J, Pradhan L, Ningthoujam RS, Vatsa RK, Bahadur D, Tyagi AK. Enhanced specific absorption rate in silanol functionalized feo core-shell nanoparticles: Study of fe leaching in feo and hyperthermia in l929 and hela cells. Colloids Surf. B. Biointerfaces 122C, 396–403 (2014).
  Google Scholar
• 4 Baldi G, Ravagli C, Mazzantini F et al. In vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted peg-based nanocarrier containing magnetic nanoparticles. Int. J. Nanomedicine 9, 3037–3056 (2014).• Confirms the possibility of using magnetic nanoparticle (MNP) containing nanocarrier as an anticancer agent against epidermoid carcinoma.
  Medline CASGoogle Scholar
• 5 Burford CD, Bhattacharyya KD, Boriraksantikul N et al. Nanoparticle mediated thermal ablation of breast cancer cells using a nanosecond pulsed electric field. IEEE Trans. Nanobiosci. 12(2), 112–118 (2013).• Demonstrates the thermal ablation of breast cancer cells using functionalized metallic nanoparticles.
  MedlineGoogle Scholar
• 6 Singh A, Sahoo SK. Magnetic nanoparticles: A novel platform for cancer theranostics. Drug Discov. Today 19(4), 474–481 (2013).
  MedlineGoogle Scholar
• 7 Shubayev VI, Pisanic TR 2nd, Jin S. Magnetic nanoparticles for theragnostics. Adv. Drug Deliv. Rev. 61(6), 467–477 (2009).
  Medline CASGoogle Scholar
• 8 Hayashi K, Nakamura M, Sakamoto W et al. Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment. Theranostics 3(6), 366–376 (2013).
  Medline CASGoogle Scholar
• 9 Laurent S, Dutz S, Hafeli UO, Mahmoudi M. Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv. Colloid Interface Sci. 166(1–2), 8–23 (2011).
  Medline CASGoogle Scholar
• 10 Gupta AK, Naregalkar RR, Vaidya VD, Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine (London, UK) 2(1), 23–39 (2007).
  Medline CASGoogle Scholar
• 11 Mccarthy JR, Kelly KA, Sun EY, Weissleder R. Targeted delivery of multifunctional magnetic nanoparticles. Nanomedicine (London, UK) 2(2), 153–167 (2007).
  Medline CASGoogle Scholar
• 12 Mikhaylova M, Kim DK, Bobrysheva N et al. Superparamagnetism of magnetite nanoparticles: Dependence on surface modification. Langmuir 20(6), 2472–2477 (2004).
  Medline CASGoogle Scholar
• 13 Warner S. Diagnostics + therapy = theranostics. Scientist 18(16), 38–39 (2004).
  Google Scholar
• 14 Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res. 60(16), 4324–4327 (2000).
  Medline CASGoogle Scholar
• 15 Torosean S, Flynn B, Axelsson J et al. Nanoparticle uptake in tumors is mediated by the interplay of vascular and collagen density with interstitial pressure. Nanomedicine 9(2), 151–158 (2013).
  Medline CASGoogle Scholar
• 16 Maeda H, Nakamura H, Fang J. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv. Drug Deliv. Rev. 65(1), 71–79 (2013).
  Medline CASGoogle Scholar
• 17 Jain PK, Huang X, El-Sayed IH, El-Sayed MA. Noble metals on the nanoscale: Optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc. Chem. Res. 41(12), 1578–1586 (2008).
  Medline CASGoogle Scholar
• 18 Wagner V, Dullaart A, Bock AK, Zweck A. The emerging nanomedicine landscape. Nat. Biotechnol. 24(10), 1211–1217 (2006).
  Medline CASGoogle Scholar
• 19 Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41, 189–207 (2001).
  Medline CASGoogle Scholar
• 20 Durymanov MOAAR, Alexander S, Sobolev AS. Current approaches for improving intratumoral accumulation and distribution of nanomedicines. Theranostics 5(9), 1007–1020 (2015).
  Medline CASGoogle Scholar
• 21 Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur. Radiol. 11(11), 2319–2331 (2001).
  Medline CASGoogle Scholar
• 22 Wu W, He Q, Jiang C. Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nanoscale Res. Lett. 3(11), 397–415 (2008).
  Medline CASGoogle Scholar
• 23 Pollert E, Veverka P, Veverka M et al. Search of new core materials for magnetic fluid hyperthermia: preliminary chemical and physical issues. Prog. Solid State Chem. 37(1), 1–14 (2009).
  CASGoogle Scholar
• 24 Chou SW, Shau YH, Wu PC, Yang YS, Shieh DB, Chen CC. In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging. J. Am. Chem. Soc. 132(38), 13270–13278 (2010).• Demonstrates the potential application of FePt nanoparticles as molecular imaging contrast agent for MRI and CT.
  Medline CASGoogle Scholar
• 25 Kim J, Rong C, Liu JP, Sun S. Dispersible ferromagnetic FePt nanoparticles. Adv. Mater. 21(8), 906–909 (2009).
  CASGoogle Scholar
• 26 Lee SJ, Cho JH, Lee C, Cho J, Kim YR, Park JK. Synthesis of highly magnetic graphite-encapsulated FeCo nanoparticles using a hydrothermal process. Nanotechnology 22(37), 375603 (2011).
  MedlineGoogle Scholar
• 27 Ennas G, Falqui A, Marras S, Sangregorio C, Marongiu G. Influence of metal content on size, dispersion, and magnetic properties of iron−cobalt alloy nanoparticles embedded in silica matrix. Chem. Mater. 16(26), 5659–5663 (2004).
  CASGoogle Scholar
• 28 Mori K, Kondo Y, Yamashita H. Synthesis and characterization of FePd magnetic nanoparticles modified with chiral binap ligand as a recoverable catalyst vehicle for the asymmetric coupling reaction. Phys. Chem. Chem. Phys. 11(39), 8949–8954 (2009).
  Medline CASGoogle Scholar
• 29 Ho D, Sun X, Sun S. Monodisperse magnetic nanoparticles for theranostic applications. Acc. Chem. Res. 44(10), 875–882 (2011).
  Medline CASGoogle Scholar
• 30 Zeng H, Li J, Wang ZL, Liu JP, Sun S. Bimagnetic core/shell FePt/Fe₃O₄ nanoparticles. Nano Lett. 4(1), 187–190 (2003).
  Google Scholar
• 31 Zeng H, Sun S, Li J, Wang ZL, Liu JP. Tailoring magnetic properties of core/shell nanoparticles. Appl. Phys. Lett. 85(5), 792–794 (2004).
  CASGoogle Scholar
• 32 Masala O, Hoffman D, Sundaram N et al. Preparation of magnetic spinel ferrite core/shell nanoparticles: soft ferrites on hard ferrites and vice versa. Solic State Sci. 8(9), 1015–1022 (2006).
  CASGoogle Scholar
• 33 Lee JH, Jang JT, Choi JS et al. Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat. Nanotechnol. 6(7), 418–422 (2011).• Demonstrates the increased antitumor efficiency of core/shell-mediated hyperthermia.
  Medline CASGoogle Scholar
• 34 Rosensweig RE. Heating magnetic fluid with alternating magnetic field. J. Magn. Magn. Mater. 252(0), 370–374 (2002).
  CASGoogle Scholar
• 35 Daniel M-C, Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 104(1), 293–346 (2003).
  Google Scholar
• 36 Chen M, Yamamuro S, Farrell D, Majetich SA. Gold-coated iron nanoparticles for biomedical applications. J. Appl. Phys. 93(10), 7551–7553 (2003).
  CASGoogle Scholar
• 37 Santra S, Tapec R, Theodoropoulou N, Dobson J, Hebard A, Tan W. Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion: the effect of nonionic surfactants. Langmuir 17(10), 2900–2906 (2001).
  CASGoogle Scholar
• 38 Tartaj P, González-Carreño T, Serna CJ. Single-step nanoengineering of silica coated maghemite hollow spheres with tunable magnetic properties. Adv. Mater. 13(21), 1620–1624 (2001).
  CASGoogle Scholar
• 39 Berry CC, Wells S, Charles S, Curtis AS. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 24(25), 4551–4557 (2003).
  Medline CASGoogle Scholar
• 40 Carmen Bautista M, Bomati-Miguel O, Del Puerto Morales M, Serna CJ, Veintemillas-Verdaguer S. Surface characterisation of dextran-coated iron oxide nanoparticles prepared by laser pyrolysis and coprecipitation. J. Magn. Magn. Mater. 293(1), 20–27 (2005).
  Google Scholar
• 41 Hee Kim E, Sook Lee H, Kook Kwak B, Kim B-K. Synthesis of ferrofluid with magnetic nanoparticles by sonochemical method for MRI contrast agent. J. Magn. Magn. Mater. 289(0), 328–330 (2005).
  Google Scholar
• 42 Li G-Y, Jiang Y-R, Huang K-L, Ding P, Yao L-L. Kinetics of adsorption of saccharomyces cerevisiae mandelated dehydrogenase on magnetic Fe₃O₄–chitosan nanoparticles. Colloids Surf. A 320(1–3), 11–18 (2008).
  CASGoogle Scholar
• 43 Li G-Y, Huang K-L, Jiang Y-R, Ding P, Yang D-L. Preparation and characterization of carboxyl functionalization of chitosan derivative magnetic nanoparticles. Biochem. Eng. J. 40(3), 408–414 (2008).
  CASGoogle Scholar
• 44 Chen F, Gao Q, Hong G, Ni J. Synthesis of magnetite core–shell nanoparticles by surface-initiated ring-opening polymerization of L-lactide. J. Magn. Magn. Mater. 320(13), 1921–1927 (2008).
  CASGoogle Scholar
• 45 Gómez-Lopera SA, Arias JL, Gallardo V, Delgado ÁV. Colloidal stability of magnetite/poly(lactic acid) core/shell nanoparticles. Langmuir 22(6), 2816–2821 (2006).
  Medline CASGoogle Scholar
• 46 Gupta AK, Curtis AS. Surface modified superparamagnetic nanoparticles for drug delivery: Interaction studies with human fibroblasts in culture. J. Mater. Sci. Mater. Med. 15(4), 493–496 (2004).
  Medline CASGoogle Scholar
• 47 Liu Z, Robinson JT, Sun X, Dai H. Pegylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 130(33), 10876–10877 (2008).
  Medline CASGoogle Scholar
• 48 Liu D, Wu W, Ling J, Wen S, Gu N, Zhang X. Effective pegylation of iron oxide nanoparticles for high performance in vivo cancer imaging. Adv. Funct. Mater. 21(8), 1498–1504 (2011).
  CASGoogle Scholar
• 49 Larsen EKU, Nielsen T, Wittenborn T et al. Size-dependent accumulation of pegylated silane-coated magnetic iron oxide nanoparticles in murine tumors. ACS Nano 3(7), 1947–1951 (2009).• Reveals an easy surface modification strategy of MNPs to enhance their dispersity in aqueous solution.
  Medline CASGoogle Scholar
• 50 Larsen EK, Nielsen T, Wittenborn T et al. Accumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumors. Nanoscale 4(7), 2352–2361 (2012).
  Medline CASGoogle Scholar
• 51 Cole AJ, David AE, Wang J, Galban CJ, Hill HL, Yang VC. Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials 32(8), 2183–2193 (2011).
  Medline CASGoogle Scholar
• 52 Cole AJ, David AE, Wang J, Galban CJ, Yang VC. Magnetic brain tumor targeting and biodistribution of long-circulating peg-modified, cross-linked starch-coated iron oxide nanoparticles. Biomaterials 32(26), 6291–6301 (2011).
  Medline CASGoogle Scholar
• 53 Zhang Y, Kohler N, Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 23(7), 1553–1561 (2002).
  Medline CASGoogle Scholar
• 54 Cohen MS, Cai S, Xie Y, Forrest ML. A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo. Am. J. Surg. 198(6), 781–786 (2009).
  Medline CASGoogle Scholar
• 55 Sun C, Sze R, Zhang M. Folic acid-peg conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J. Biomed. Mater. Res. A. 78A(3), 550–557 (2006).• Reports an MNPs-based nanoconjugate to achieve targeted tumor delivery and enhance the MRI contrast.
  CASGoogle Scholar
• 56 Strupp J. Stimulate: a GUI based fMRI analysis software package. NeuroImage 3(3), S607 (1996).
  Google Scholar
• 57 Wei DH, Yao YD. Magnetization reversal mechanism and microstructure refinement of the FEPT (001) nanogranular films with sio2 capping layer. IEEE Trans. Magn. 45(10), 4092–4095 (2009).
  CASGoogle Scholar
• 58 Lin Z, Cai W, Jiang W, Fu C, Li C, Song Y. Effects of annealing temperature on the microstructure, optical, ferroelectric and photovoltaic properties of bifeo3 thin films prepared by sol–gel method. Ceram. Int. 39(8), 8729–8736 (2013).
  CASGoogle Scholar
• 59 Mei Hyie K, Yaacob II. Annealing behavior of fept ferromagnetic nanoparticles prepared in water-in- oil microemulsions. AIP Conf. Proc. 1138(1), 117–128 (2009).
  CASGoogle Scholar
• 60 Nguyen HL, Howard LEM, Stinton GW et al. Synthesis of size-controlled fcc and fct fept nanoparticles. Chem. Mater. 18(26), 6414–6424 (2006).
  CASGoogle Scholar
• 61 Kang S, Jia Z, Nikles DE, Harrell JW. Synthesis, self-assembly, and magnetic properties of [FEPT]/sub 1-x/au/sub x/nanoparticles. IEEE Trans. Magn. 39(5), 2753–2757 (2003).
  CASGoogle Scholar
• 62 Mills N. 150 And More Basic NMR Experiments: A Practical Course (2nd edition). Braun S, Kalinowski H-O, Berger S (Eds). J. Chem. Educ. 77(7), 831 (2000).
  CASGoogle Scholar
• 63 Habib AH, Ondeck CL, Chaudhary P, Bockstaller MR, Mchenry ME. Evaluation of iron-cobalt/ferrite core-shell nanoparticles for cancer thermotherapy. J. Appl. Phys. 103(7), (2008).
  Google Scholar
• 64 Maenosono S, Saita S. Theoretical assessment of fept nanoparticles as heating elements for magnetic hyperthermia. IEEE Trans. Magn. 42(6), 1638–1642 (2006).
  CASGoogle Scholar
• 65 Inomata K, Sawa T, Hashimoto S. Effect of large boron additions to magnetically hard Fe–Pt alloys. J. Appl. Phys. 64(5), 2537–2540 (1988).
  CASGoogle Scholar
• 66 Ma M, Wu Y, Zhou J, Sun Y, Zhang Y, Gu N. Size dependence of specific power absorption of Fe₃O₄ particles in AC magnetic field. J. Magn. Magn. Mater. 268(1–2), 33–39 (2004).
  CASGoogle Scholar
• 67 Yamazaki M, Ito T. Deformation and instability in membrane structure of phospholipid vesicles caused by osmophobic association: mechanical stress model for the mechanism of poly(ethylene glycol)-induced membrane fusion. Biochemistry 29(5), 1309–1314 (1990).
  Medline CASGoogle Scholar
• 68 Dobretsov K, Stolyar S, Lopatin A. Magnetic nanoparticles: a new tool for antibiotic delivery to sinonasal tissues. Results of preliminary studies. Acta Otorhinolaryngol. Ital. 35(2), 97–102 (2015).
  Medline CASGoogle Scholar
• 69 Chen J, Wu H, Han D, Xie C. Using anti-VEGF MCAB and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancer. Cancer Lett. 231(2), 169–175 (2006).
  Medline CASGoogle Scholar
• 70 Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53(2), 283–318 (2001).
  Medline CASGoogle Scholar
• 71 Duguet E, Vasseur S, Mornet S, Devoisselle JM. Magnetic nanoparticles and their applications in medicine. Nanomedicine (London, UK) 1(2), 157–168 (2006).
  Medline CASGoogle Scholar
• 72 Bulte JWM, Cuyper MD, Despres D, Frank JA. Preparation, relaxometry, and biokinetics of pegylated magnetoliposomes as mr contrast agent. J. Magn. Magn. Mater. 194(1–3), 204–209 (1999).
  CASGoogle Scholar
• 73 Tong Q, Li H, Li W et al. In vitro and in vivo anti-tumor effects of gemcitabine loaded with a new drug delivery system. J. Nanosci. Nanotechnol. 11(4), 3651–3658 (2011).
  Medline CASGoogle Scholar
• 74 Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46(12 Pt 1), 6387–6392 (1986).
  Medline CASGoogle Scholar
• 75 Danhier F, Feron O, Preat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release 148(2), 135–146 (2010).
  Medline CASGoogle Scholar
• 76 Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the epr effect in macromolecular therapeutics: a review. J. Control. Release 65(1–2), 271–284 (2000).
  Medline CASGoogle Scholar
• 77 Sawant R, Sawant R, Gultepe E et al. Nanosized cancer cell-targeted polymeric immunomicelles loaded with superparamagnetic iron oxide nanoparticles. J. Nanopart. Res. 11(7), 1777–1785 (2009).
  CASGoogle Scholar
• 78 Wang R, Billone PS, Mullett WM. Nanomedicine in action: an overview of cancer nanomedicine on the market and in clinical trials. J. Nanomater. 2013, 12 (2013).
  CASGoogle Scholar
• 79 Dudar TE, Jain RK. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res. 44(2), 605–612 (1984).
  Medline CASGoogle Scholar
• 80 Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res. 60(16), 4440–4445 (2000).
  Medline CASGoogle Scholar
• 81 Ito A, Tanaka K, Honda H, Abe S, Yamaguchi H, Kobayashi T. Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles. J. Biosci. Bioeng. 96(4), 364–369 (2003).
  Medline CASGoogle Scholar
• 82 Du L, Zhou J, Wang X et al. Effect of local hyperthermia induced by nanometer magnetic fluid on the rabbit Vx2 liver tumor model. Progr. Nat. Sci. 19(12), 1705–1712 (2009).
  Google Scholar